ALTUCCI, Lucia
 Distribuzione geografica
Continente #
EU - Europa 28.441
NA - Nord America 18.163
AS - Asia 11.458
SA - Sud America 2.017
Continente sconosciuto - Info sul continente non disponibili 837
AF - Africa 173
OC - Oceania 20
Totale 61.109
Nazione #
US - Stati Uniti d'America 17.647
RU - Federazione Russa 17.499
SG - Singapore 4.057
IT - Italia 3.470
IE - Irlanda 2.702
CN - Cina 2.408
HK - Hong Kong 1.845
BR - Brasile 1.701
VN - Vietnam 1.287
UA - Ucraina 1.067
GB - Regno Unito 1.058
DE - Germania 853
KR - Corea 562
FI - Finlandia 434
IN - India 368
SE - Svezia 297
CA - Canada 220
FR - Francia 211
TR - Turchia 210
GR - Grecia 208
JP - Giappone 152
AR - Argentina 139
NL - Olanda 135
BD - Bangladesh 125
MX - Messico 102
PK - Pakistan 83
AT - Austria 82
BE - Belgio 77
ES - Italia 64
ID - Indonesia 57
ZA - Sudafrica 55
IQ - Iraq 51
EC - Ecuador 50
PL - Polonia 49
CR - Costa Rica 42
HU - Ungheria 37
CO - Colombia 30
VE - Venezuela 29
JM - Giamaica 28
UZ - Uzbekistan 28
DK - Danimarca 26
MA - Marocco 26
RO - Romania 24
LT - Lituania 22
AZ - Azerbaigian 20
HN - Honduras 19
CL - Cile 18
GT - Guatemala 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 17
EG - Egitto 17
AU - Australia 16
CH - Svizzera 16
IL - Israele 15
IR - Iran 15
PE - Perù 15
TT - Trinidad e Tobago 15
AL - Albania 14
JO - Giordania 14
MY - Malesia 14
PT - Portogallo 14
SC - Seychelles 14
TN - Tunisia 14
KE - Kenya 13
TW - Taiwan 13
PR - Porto Rico 12
SA - Arabia Saudita 12
TH - Thailandia 12
BG - Bulgaria 11
CW - ???statistics.table.value.countryCode.CW??? 11
NP - Nepal 11
PH - Filippine 11
SV - El Salvador 11
EU - Europa 10
KZ - Kazakistan 10
BS - Bahamas 9
DZ - Algeria 9
PS - Palestinian Territory 9
ET - Etiopia 8
HR - Croazia 8
NO - Norvegia 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
GP - Guadalupe 7
LV - Lettonia 7
RS - Serbia 7
AM - Armenia 6
BO - Bolivia 6
LB - Libano 6
NI - Nicaragua 6
EE - Estonia 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
PA - Panama 5
SI - Slovenia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
KH - Cambogia 4
Totale 60.227
Città #
Moscow 6.276
Dublin 2.686
Hong Kong 1.809
Santa Clara 1.808
Singapore 1.807
San Jose 1.793
Jacksonville 1.623
Ashburn 1.345
Chandler 1.204
Council Bluffs 946
Chicago 605
Wilmington 579
Seoul 527
Naples 449
Beijing 446
Princeton 403
Ho Chi Minh City 401
Hefei 358
Falls Church 341
Milan 341
Caserta 312
Hanoi 300
Medford 287
New York 286
Boardman 275
Roxbury 243
Dallas 217
Ann Arbor 212
Bengaluru 211
Los Angeles 183
The Dalles 178
Munich 162
Rome 145
São Paulo 143
San Mateo 132
Aversa 128
Bremen 114
Cambridge 107
Napoli 99
Woodbridge 98
Helsinki 95
Orem 89
Miano 82
Mountain View 77
Atlanta 74
Des Moines 73
Da Nang 69
Rio de Janeiro 65
Brussels 63
Nanjing 63
Nuremberg 63
Haiphong 61
Turku 58
North Bergen 57
Amsterdam 52
Brooklyn 52
Phoenix 52
Houston 51
Vienna 48
Frankfurt am Main 47
Memphis 47
Dong Ket 44
Montreal 43
Venice 42
Warsaw 40
Chennai 39
Boston 37
Norwalk 37
Tokyo 37
Curitiba 36
Düsseldorf 36
San Francisco 36
Guangzhou 34
Mexico City 34
Belo Horizonte 33
Buenos Aires 32
San José 32
Lappeenranta 31
Tianjin 31
Brasília 29
Jinan 29
London 29
Porto Alegre 29
Denver 28
Salvador 28
Biên Hòa 27
Columbus 26
Florence 26
Toronto 26
Hải Dương 25
Jakarta 25
Seattle 25
Afragola 24
Fisciano 24
Paris 24
Tashkent 24
Ercolano 23
Hillsboro 23
Istanbul 23
Thái Nguyên 23
Totale 32.111
Nome #
Epigenetic mechanisms underlying prostate cancer radioresistance 1.443
NETosis in pathologies: a preliminary study for NETs detection in vitro 397
POLYPHENOLIC EXTRACTS FROM STRAWBERRY CULTIVARS MODULATE INFLAMMATION IN HUMAN LEUKEMIA CELLS 341
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 314
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 302
D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts 235
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 230
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma 227
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells 219
Epi-Drugs Targeting RNA Dynamics in Cancer 216
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 212
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 212
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 209
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells 208
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 207
A genic and epigenetic combination therapy for liver cancer 205
HIF3A inhibition triggers browning of white adipocytes via metabolic rewiring. 205
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 203
A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up 197
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia 197
1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. 196
Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement 193
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis 192
Characterization of the biological role of RIPK2 in carcinogenesis 191
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 191
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 188
IMMUNOMODULATORY ACTIVITY OF POLYPHENOLIC EXTRACTS FROM STRAWBERRY CULTIVARS 188
CBX3 as a prognostic biomarker in lung cancer 186
Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies 186
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 186
Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells 186
(INVITED)Quantitative detection of SARS-CoV-2 virions in aqueous mediums by IoT optical fiber sensors 183
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 183
Deregulation of new cell death mechanisms in Leukemia 182
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 182
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 182
Epigenetic drugs against cancer: an evolving landscape. 181
Characterization of Histone Acetyltransferase-1 in cancer cells 181
A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome 180
Altered folate receptor 2 expression in uraemic patients on haemodialysis: Implications for folate resistance 179
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 178
ATTIVITÀ ANTI-PROLIFERATIVA E DIFFERENZIANTE INDOTTA DAL FRUTTO DI PSIDIUM GUAJAVA IN CELLULE LEUCEMICHE UMANE 178
Antioxidant, antimicrobial and anti-proliferative activities of Solanum tuberosum L. var. Vitelotte. 177
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 175
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells 175
CHARACTERIZATION OF NEW RIPKs FAMILY MEMBERS: HIGHLIGHTS ON THE BIOLOGICAL ROLE OF RIPK2 AND RIPK4 IN CANCER 173
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 172
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 171
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients:a meta-analysis of randomized clinical trials 171
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells 170
Combined HAT/EZH2 modulation leads to cancer-selective cell death 169
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 168
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics 168
Targeting the NLRP3 Inflammasome as a Potential Epigenetic Therapy in Leukemia 167
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 167
17ƒÒ-estradiol overcomes a cell cycle block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and ERK-2 MAP kinases activation 167
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model 167
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch 166
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 166
Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. 165
Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric Species. 165
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 165
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A 164
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery 164
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 163
Enigmatic role of RIPK1 in leukemia 162
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 162
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 162
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. 162
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 162
Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis 162
Comparative phytochemical characterization, genetic profile, and antiproliferative activity of polyphenol-rich extracts from pigmented tubers of different solanum tuberosum varieties 162
Age-related miRNome landscape of cumulus oophorus cells during controlled ovarian stimulation protocols in IVF cycles 162
MRI Radiomics in Prostate Cancer: A Reliability Study 162
Breast Cancer Vaccines: New Insights 161
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer 161
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 159
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis 159
A DNA Methyltransferase Modulator Inspired by Peyssonenyne Natural Product Structures. 158
17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation 158
ATTIVITA’ ANTITUMORALE DEL FLAVONE NATURALE PURIFICATO DA FEIJOA SELLOWIANA IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 158
Epigenetic-based therapy: From single- to multi-target approaches 158
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer 158
Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives 157
Involvement of regulated cell deaths in aging and age-related pathologies 157
HAT1: Landscape of Biological Function and Role in Cancer 157
The m6A-independent role of epitranscriptomic factors in cancer 156
3-Chloro-N '-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy 156
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 156
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 156
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 155
CRUDE ANTHOCYANIN EXTRACT FROM CAPSICUM CHINENSE REGULATES THE CELL CYCLE AND CAUSES CELL DEATH IN HUMAN LEUKEMIA CELLS 154
. Estrogen and protooncogenes in cell cycle regulation 154
3D-printed biosensors in biomedical applications exploiting plasmonic phenomena and antibody self-assembled monolayers 153
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 153
Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement 153
Modulation of Autophagy and Apoptosis in Leukemia 153
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 152
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 151
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. 151
Totale 19.438
Categoria #
all - tutte 205.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.442 0 0 0 159 842 76 94 75 116 150 195 735
2022/20235.436 514 205 435 384 465 386 19 242 2.497 46 104 139
2023/20242.495 201 70 107 210 668 315 67 121 34 86 196 420
2024/20257.540 93 135 197 274 1.183 939 1.300 682 823 824 563 527
2025/202630.366 1.266 1.520 1.547 1.634 2.363 16.363 1.451 1.169 1.195 815 692 351
2026/20275.472 312 974 1.960 2.226 0 0 0 0 0 0 0 0
Totale 61.109